What’s coming in Cegeka Pharma & Life Sciences for Dynamics 365

The pharma and life sciences industry operates in one of the most demanding and regulated environments. You're expected to maintain GMP compliance, respond to evolving regulations, streamline production, and ensure every batch is fully traceable, all while minimizing complexity and keeping teams aligned across systems.

That’s why Cegeka developed Cegeka Pharma & Life Sciences, a dedicated solution built on top of Microsoft Dynamics 365 Finance & Supply Chain Management. It accelerates ERP implementations for pharma companies and delivers industry-specific capabilities out of the box.

Every year, we deliver two dedicated release waves that include new features and enhancements to support evolving business needs, as well as improve performance and usability.

June 2025: enhancements that make an immediate impact

1. Granular control over batch disposition changes
   We’re expanding the matrix for allowed batch disposition changes. You’ll now be able to define permissions for changing the quality status of a batch by individual item or product family, for example to limit the release of API batches only to QA personnel. It’s a practical step toward better compliance without adding complexity.
   
   
2. Certificate of Conformity/Conformance (CoC)
   To complement the existing Certificate of Analysis (CoA), we’re introducing a standard report for the Certificate of Conformity/Conformance (CoC). To comply with regulatory requirement, this document can be issued for each batch to legally state that the product has been manufactured and is in conformance with respect to the requirements from standards or specifications specified in the market’s regulation.
   
   
3. Quality orders at earlier production stages
   Manufacturers can now trigger quality orders not just after the production process is complete, but at earlier milestones, including order release and start. This allows you to begin collecting quality data proactively, even before production is finalized.
   
   
4. Precision check for weighing scales
   Our weighing scale integration now includes precision checks. The system will verify that selected scales are not only calibrated, but also appropriate for the target quantity to be weighed based on the accuracy/precision of the scale itself. This is meant to minimize errors and ensure confidence in weight measurements during the weighing & dispensing, material consumption and production report as finished processes.

December 2025 and ahead

We’re already laying the groundwork for future capabilities. Our product roadmap is designed to address the evolving needs of pharmaceutical companies, with a focus on delivering robust, compliant, and innovative solutions that support operational excellence and regulatory requirements. Here are a few examples of the topics we’ll be focusing on:

1. Quality order results entry mobile app
   We’ll introduce an innovative flow to let warehouse workers, production operators or QC analysts register the results of checks on the quality of the incoming and stored goods on any mobile device, without the need to log on to a physical workstation (computer or laptop). This will provide enhanced efficiency, compliance, and data integrity in GMP-regulated quality control processes.
   
   
2. Country-specific shipping controls
   Regulatory compliance will take a leap forward with enhanced controls over approved shipping destinations. Companies will be able to define product eligibility not just by customer, but also by country or specific customer-country combinations. This will make it possible to ensure products are delivered only to destinations that hold a valid marketing authorization or import license.
   
   
3. Sunshine Act reporting
   Organizations operating in the U.S. will benefit from built-in tools to manage compliance with Sunshine Act reporting requirements. This feature will support detailed tracking of payments and expenses related to HCPs and HCOs, thus increasing transparency and reducing the risk of penalties and reputational damage.
   
   
4. CoC customization by customer
   To responding to market demands, Certificate of Conformity/Conformance (CoC) documents will become customer-configurable. This means different customers will be able to receive personalized document formats with different layout and content, vital for organizations that serve diverse regulatory markets.

The bigger picture

These updates reflect a product vision deeply rooted in user feedback, regulatory needs, and ongoing innovation. Features are prioritized through a rigorous review by a centralized product board, ensuring each release aligns with customer requirements and evolving industry standards.

The roadmap is packed with functionality that empowers pharmaceutical manufacturers to be more precise, compliant, and responsive. For those aiming to stay ahead, now is the time to align internal processes and prepare to adopt these powerful enhancements.

Want to learn more about the features and benefits of this release? 
Schedule a demo and discover how Cegeka Pharma & Life Sciences can help you stay compliant, efficient, and ready for the future.